|
|
|
European Pharmaceutical Contractor
|
| Amy Furlong at eResearchTechnology, Inc examines quality control and quality assurance for ECG core laboratories
Recent regulatory guidance for electrocardiographic (ECG) analysis has raised new considerations and challenges for sponsors when designing drug development programmes. As part of these initiatives, the role of the ECG core laboratory has been redefined as a ‘trusted third party’ for the generation, management and delivery of digital ECG files. As a result, mandatory quality programmes for the ECG core laboratory have expanded from assuring the accuracy and precision of key ECG endpoints to now including a complex combination of evolving technologies, processes and data verification techniques in the collection, evaluation and management of digital data files. The successful collection of quality ECG data in the digital era is highly dependent upon superior technology and user training based on predefined processes to properly collect, identify and process ECGs.
To this end, there are several logistical, equipment, data and record management issues that the ECG core laboratory must undertake, in addition to the clinical ECG analysis methodology itself. There are a number of technology solutions, ECG analyses, evaluation methodologies and data management decisions to be made. In the definition of adequate and wellcontrolled ECG studies, a balance of these factors must be found to determine the approach that best suits each protocol. The ECG core laboratory should have the flexibility and experience to make these decisions in a validated and controlled environment. |
Read full article from PDF >>
|
 |
 |
 |
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|

 |
Industry Events |
 |
DIA Annual EuroMeeting
26-28 March 2012, Copenhagen, Denmark
The EuroMeeting attracts more than 3,000 professionals from over 50 countries. It brings together professionals from the biopharmaceutical industry, contract service organisations, clinical research, regulatory agencies, health ministries, patients’ organisations and universities. This convergence affords attendees the opportunity to network with professional colleagues from around the world.
More info >> |
|
 |
News and Press Releases |
 |
Prism Ideas and dMetrics Launch Pioneering Service Analysing Patient–Reported Action, Behaviours and Outcomes with Social Media
Prism Ideas, the multi-national medical marketing and drug development consultants, today announced its collaboration with dMetrics, experts in identifying decisions made by millions of patients online, to launch a pioneering analysis service to evaluate patient healthcare outcomes reported within social media. Combining expertise in language analytics and healthcare, the two companies are interrogating social media to determine patient actions and insights, profiling patient needs, symptoms and response to treatment.
More info >> |
|
|